医学
Graves眼病
格雷夫斯病
视神经病变
优势比
外科
皮肤病科
疾病
内科学
眼科
视神经
作者
Vahab Fatourechi,George B. Bartley,Guiti Z. Eghbali-Fatourechi,Claudia C. Powell,Debra D. F. Ahmed,James A. Garrity
出处
期刊:Thyroid
[Mary Ann Liebert, Inc.]
日期:2003-12-01
卷期号:13 (12): 1141-1144
被引量:46
标识
DOI:10.1089/10507250360731541
摘要
It is generally considered that thyroid dermopathy and acropachy almost always occur with Graves' ophthalmopathy and that these two extrathyroidal manifestations are indicators of severe autoimmune disease and hence of more severe ophthalmopathy. However, documentation of these anecdotal impressions is needed. We assessed the presence of optic neuropathy and frequency of orbital decompression in 2 referral cohorts: 40 patients with acropachy and dermopathy (acropachy group) and 138 patients with Graves' dermopathy and no acropachy (dermopathy group). We compared those cohorts with a cohort of 114 patients who had ophthalmopathy without dermopathy and acropachy (control group). We considered optic neuropathy and the need for orbital decompression to be indicators of severe Graves' ophthalmopathy. The frequency of orbital decompression was significantly higher in the dermopathy group than in the control group (odds ratio, 3.55) and even higher in the acropachy group (odds ratios: 20.68 for acropachy group compared with control group; 5.83 for acropachy group compared with dermopathy group). The same trend occurred with optic neuropathy but was not statistically significant (alpha = 0.05; p = 0.07). Five patients were exceptions: they had definite Graves' dermopathy without clinically obvious ophthalmopathy. In conclusion, dermopathy and acropachy appear to be markers of severe ophthalmopathy. Occasionally, however, Graves' dermopathy occurs without clinical ophthalmopathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI